Dana-Farber Cancer Institute
Nabeel Bardeesy, Ph.D.
Pancreatic Cancer Models for The Identification of Biomarkers and Tumor Maintenance Programs
Johns Hopkins Medical Institutions
Anirban Maitra, MBBS
Hedgehog Inhibitors of Pancreatic Cancer
Mayo Clinic College of Medicine
Janet Olsen, Ph.D.
Identification of Early Stage Pancreatic Cancer Biomarkers using LC-Dual ESI-FT-ICR Mass Spectrometry
Mayo Clinic at Rochester
Suresh T. Chari, M.D.
Serum Proteomics of Pancreatic Cancer- Induced Diabetes
Meharry Medical College and Vanderbilt University
Ana M. Grau, M.D.
Role of Rhob in Tumorigenesis and Metastasis In Pancreatic Cancer
Memorial Sloan-Kettering Cancer Center
Richard N. Kolesnick, M.D.
Development of KSR Phosphorothioate Antisense Oligonucleotides in the Treatment of Human Pancreatic Cancer
Mt. Sinai Hospital, Toronto / Samuel Lunenfeld Research Institute
Steven Gallinger, M.D.
A Novel Pancreatic Cancer Tumor Suppressor Candidate Gene
New York University School of Medicine
Daniel Meruelo, Ph.D.
Imaging-Assisted Design of Viral Vectors to Eradicate Metastatic Pancreatic Cancer
Paul Grippo, Ph.D.
Dual Targeting of Mutant Kras And Muchin1 in Mice That Develop Human Like Panins
Stanford University School of Medicine
Jonathan Pollack, M.D., Ph.D.
Locating Novel Pancreatic Cancer Genes with DNA Microarrays
State University of New York at Stony Brook
Dafna Bar-Sagi, Ph.D.
Analysis of Pancreatic Ductal Adenocarcinoma Progression in a Mouse Model of Hereditary Pancreatitis
University of Alabama at Birmingham
Pierre L. Triozzi, M.D.
ErbB Receptor Immunotherapy
University of California at San Francisco
Matthias Hebrok, Ph.D.
Embryonic Signaling Pathways in Pancreatic Cancer
University of Michigan Medical Center
Diane M. Simeone, M.D.
Development and Validation of Novel Biomarkers for Early Pancreatic Cancer Detection